and migratory dynamics of the migrating cells resembles that of cortical interneurons. This approach enhances the repertoire of phenotypic assays available for cerebral organoids and in turn enhances their potential as models to study the developmental cell biology of human neurological disease.
The cerebral cortex contains two main populations of neurons, excitatory glutamatergic pyramidal neurons and inhibitory g-aminobutyric acid (GABA)-producing interneurons 1 . The former are predominantly generated by dorsal forebrain progenitors and the latter by ventral forebrain progenitors 2 . To integrate into cortical circuits, interneurons perform a long-distance migration from their ventral origin into their target dorsal cortical regions 3 . This migration is controlled by many signaling pathways 4, 5 , and studies using animal models indicate that mutations in some neurological-disease-associated genes can disrupt interneuron migration 6, 7 . However, without suitable experimental human model systems, the relationship between patient-specific mutations and human brain development remains enigmatic.
3D organoid culture technology allows the development of complex, organ-like tissues reminiscent of in vivo development 8 . Importantly, cerebral organoids recapitulate many aspects of embryonic cortical development, including the generation of diverse cell types corresponding to different brain regional identities such as dorsal and ventral forebrain progenitors 9 . Cerebral organoids can be generated from human-patient-derived induced pluripotent stem cells (hiPSCs), and they have been used for functional genomic studies of neurological disorders such as microcephaly 9 and autism 10 . These organoids represent an exemplary experimental system to study the role of neurological-disease-associated genes in brain development.
In this study, we expand the potential of the cerebral organoid model system. We developed an organoid coculture 'fusion' paradigm to combine independently patterned organoids into a single tissue. Using this approach, we recreated the dorsal-ventral forebrain axis; and, by labeling one organoid with a fluorescent reporter, used this system to study neuronal migration. The molecular taxonomy organoids as 'control' , we refer to them as 'dorsal Unt ' to accurately depict their dorsal patterning while also conveying their reliance on an intrinsic (untreated) patterning protocol. In contrast, ventral organoids contained only small regions of PAX6 + or TBR1 + tissue (Fig. 1e) .
Additionally, we quantified the percentage of ventricular zone (VZ)-like progenitor regions expressing various dorsal and ventral markers in dorsal Unt and ventral organoids ( Supplementary  Fig. 1) . In both dorsal Unt and ventral organoids, the number of FOXG1 + VZ-like regions was similar. The dorsal Unt organoids were nearly all dorsal tissue (96% TBR1 + and 76% PAX6 + ) with GSX2 was expressed in control organoids, but increased in ventral organoids (Fig. 1c) . Expression of NKX2-1 and LHX6 was undetectable in control organoids but largely increased in ventral organoids ( Fig. 1c) . Finally, immunostaining confirmed the qPCR results indicating widespread expression of FOXG1 in control and ventral organoids, but only ventral organoids expressed the ventral forebrain marker NKX2-1 (Fig. 1d) . Ventral organoids also highly expressed the ventral markers DLX2 and GSX2 (Supplementary Fig. 1e-f) .
Intriguingly, control organoids mainly expressed dorsal forebrain markers for both progenitors (PAX6) 29 and early born neurons (TBR1) 20 (Fig. 1e) . Therefore, rather than referring to these only small amounts of ventral tissue (0% NKX2-1 + , 5% DLX2 + , and 6% GSX2 + ). In contrast, the ventral organoid progenitor regions were highly positive for ventral markers (73% NKX2-1 + , 97% DLX2 + , and 100% GSX2 + ). We conclude that WNT inhibition and enhanced SHH signaling produces ventral cerebral organoids at the expense of dorsal tissue. We note that this procedure has until now been tested in a single human pluripotent stem cell (hPSC) line which we use extensively in the lab for growing forebrain organoids. When extending this protocol to additional lines, qPCR analysis ( Fig. 1) could be used to test the efficacy of the ventralizing treatment.
Fused cerebral organoids recreate a dorsal-ventral axis
To recreate a dorsal-ventral axis in a single tissue, we developed an organoid coculture method, which we termed organoid 'fusion' . As we have discussed, dorsal Unt organoids produced mostly dorsal forebrain tissue (Fig. 1c,e and Supplementary Fig. 1 ). However, inhibition of SHH activity with the smoothened receptor inhibitor cyclopamine A (CycA) can enhance dorsal forebrain identity in 2D neuronal differentiation from hPSCs 30 . Therefore, we treated organoids with CycA during the neural induction step of the cerebral organoid protocol ( Fig. 2a) , and we refer to these organoids as 'dorsal CycA ' .
In this approach, embryoid bodies (EBs) are individually patterned into either dorsal CycA or ventral (IWP2 + SAG) forebrain organoids ( Fig. 2a,b) . After patterning, a ventral and a dorsal CycA EB are embedded together within a single Matrigel droplet ( Fig. 2a) ; over time the organoids grow together and become fused (Fig. 2b) . The successful fusion of organoids occurred in more than 90% of organoid fusions within a given batch (~100 fusions).
Fusions around 45-60-d old retained structural organization, and VZ-like regions were observed. As we have also found in the traditional organoid protocol 9,12 , VZ-like regions were not observed in 80-d-old organoid fusions ( Supplementary Fig. 2) 9, 12 . Immunostaining of fused ventral::dorsal CycA organoids revealed a continuous tissue where one side expressed the ventral marker NKX2-1, while the opposite side was positive for the dorsal marker TBR1 (Fig. 2c) . This suggests that organoid fusion juxtaposes dorsal and ventral forebrain regions in an arrangement similar to that occurring during brain development. cells 5 . These cells are identified by the expression of the protein reelin (RELN) 32, 33 . The migratory GFP + cells in organoid fusions did not express RELN ( Supplementary Fig. 4 ) despite the substantial presence of GFP -, RELN + cells in the dorsal target region of organoid fusions. Thus, our data indicate that the migratory GFP + cells in organoid fusions are not Cajal-Retzius cells. In combination with our previous results, these data strengthen the evidence that these cells are GABAergic interneurons. Finally, we analyzed the migrating GFP + cells for the expression of various neuronal markers-the pan-neuronal marker HuC/D 34 , the immature migrating neuron marker DCX 35 , and the mature neuronal markers NeuN 35 and MAP2 36 . We observed that all the migrated GFP + cells expressed HuC/D, and this indicated the cells' neuronal identity ( Fig. 4d,f ). In addition, many GFP + cells expressed DCX ( Supplementary Fig. 5a ), and a subset of these cells also expressed NeuN (Supplementary Fig. 5a ) or MAP2 ( Supplementary Fig. 5b ). This indicates not only that the migrating GFP + cells are neurons (HuC/D + or DCX + ), but also that they can become mature neurons (DCX + /NeuN + or MAP2 + ). Indeed, we observed that some of the GFP + cells had a more mature morphology, with branched Directed neuronal migration within fused cerebral organoids During in vivo brain development, GABAergic interneurons originate in ventral forebrain progenitor regions before migrating to their dorsal forebrain targets 4,5 . To test whether cells could migrate between the fused organoids, we used cell lines containing either a ubiquitous GFP or tdTomato reporter to create ventral/GFP + ::dorsal CycA / tdTomato + organoid fusions. We observed many GFP + cells within the tdTomato + /GFPdorsal CycA part of the organoid (Fig. 2d ) but very few tdTomato + cells within the ventral GFP + tissue (Fig. 2d) . We next analyzed the timecourse of the ventral-to-dorsal migration using organoid fusions of different ages. Migrating cells were observed in small numbers around day 30 ( Fig. 2e,f) . Their density increased from day 30 to day 46, but we did not observe a further increase from day 46 to day 80 ( Fig. 2f) . Nevertheless, since organoids increase in size with age, the absolute numbers of migrated cells must increase over time to maintain a similar density. Alternatively, increased proliferation of the migrating cells could explain their increased, and then maintained, cell density over time. To test this possibility, we examined the expression of a marker of cell proliferation (Ki67) in the migrating GFP + cells ( Supplementary Fig. 3 ). We observed that few (≤1%) of the GFP + cells expressed Ki67 at either day 46 or day 80 ( Supplementary  Fig. 3b ), which indicated that the GFP + cells are largely postmitotic and have likely migrated from the ventral to the dorsal regions of the fused organoids. Since the cell density did not increase from day 46 to day 80 ( Fig. 2f) , we focused our subsequent analysis on organoids older than ~50 d.
To more systematically test whether the directionality of in vivo interneuron migration is recapitulated in fused cerebral organoids, we varied the identities (dorsal or ventral) of the individual organoid fusion tissue components ( Fig. 3) and used fluorescent-reporter labeling (GFP::tdTomato) to analyze the number of cells migrating in both directions. Whole-mount imaging of ventral::dorsal Unt and ventral::dorsal CycA fusions showed GFP + spots within the tdTomato + tissue (Fig. 3a ), but these were rarely observed in dorsal Unt ::dorsal Unt or dorsal CycA ::dorsal CycA fusions ( Fig. 3a) . We did not analyze ventral::ventral fusions. Similarly, quantitative analysis of immunostained cryosections showed the largest number of migrating cells in ventral::dorsal Unt and ventral::dorsal CycA fusions, while the least migration occurred in dorsal CycA ::dorsal CycA fusions (Fig. 3b,c) . Although the average density of migrating cells in ventral::dorsal Unt fusions was not significantly different than that in ventral::dorsal CycA fusions, the latter fusions were less variable ( Fig. 3c) . These data confirm our observation of directionally biased migration from ventral into dorsal tissue in fused organoids.
Interneurons migrate between fused cerebral organoids
We tested whether the cells migrating through fused organoids were GABAergic by examining whether they expressed GAD1, one of the key enzymes for the synthesis of GABA 31 . Immunostaining revealed that the GFP + cells that had migrated into the target organoid broadly expressed GAD1 ( Fig. 4a-c) , and cell counting indicated that ~60% of the GFP + cells expressed GAD1 (Fig. 4) . Strikingly, when visualizing the entire organoid, GAD1 was expressed in a pattern similar to that of the GFP + migrating cells ( Fig. 4a) . Additionally, the expression of GAD1 appeared stronger in regions near the edge of the organoid (Fig. 4b) and farther away from the origin of the migrating cells.
Another major population of tangentially migrating cells in the developing human brain are the non-GABAergic Cajal-Retzius processes and a circular cell body ( Supplementary Fig. 6a ). Other cells exhibited a migratory morphology with an elongated cell body, a branched leading process, and a trailing process ( Supplementary  Fig. 6b,c) .
We observed that ~20% of the GFP + migrating cells in dorsal-CycA organoid regions expressed NKX2-1 ( Fig. 4e,f) . During normal mouse brain development, cortical interneurons downregulate the expression of NKX2-1 as they migrate toward dorsal cortical regions 37 . The maintained expression of NKX2-1 in our fused organoids could indicate an immature status of the migrating cells, but it could also reflect a difference between the development of mouse and human interneurons.
Interestingly, many NKX2-1 + or GAD1 + cells that were GFPwere present within the dorsal CycA region of organoid fusions (Figs. 2c and 4e); this indicated the production of ventral regions within the dorsal organoid. In contrast, dorsal Unt organoids were nearly entirely of dorsal forebrain identity when not fused (Fig. 1c,e and Supplementary  Fig. 1) . Therefore, the tissue components of organoid fusions must be able to signal to each other; the ventral organoid may be able to influence the patterning of nearby dorsal tissue toward a ventral fate. Importantly, this does not affect the analysis of ventral-to-dorsal migrating cells, because these cells are uniquely labeled with GFP. Taken together, our results show that interneurons can migrate within fused ventral::dorsal CycA organoids.
Cortical interneuron subtypes in fused cerebral organoids
We tested which interneuron subtypes are produced by the predominantly GABAergic cells migrating in fused organoids. Interneurons are heterogeneous, and multiple molecular markers can be used to identify various subtypes 38, 39 generated by distinct progenitor subpopulations within the ventral forebrain 3, [23] [24] [25] [26] 40 . In humans, the majority of interneurons are generated from NKX2-1 + regions of the MGE 41, 42 . Therefore, we tested whether the migrating GFP + cells produce MGE-derived interneuron subtypes. In humans, SOX6 is expressed in the MGE and in immature and mature interneurons emerging from this region 41 . In organoid fusions, we found that ~40% of the migrating GFP + /GAD1 + cells are SOX6 + MGE interneurons ( Fig. 5) . To confirm this finding, we examined the expression of additional markers for MGE-derived interneurons 3, 39, 40 . We observed expression of somatostatin (SOM) ( Fig. 5b,i) in 6%, neuropeptide Y (NPY) (Fig. 5c,i) in 6%, calbindin D-28k (CB) (Fig. 5d,i) in 20%, and parvalbumin (PV) (Fig. 5e,i) in 5% of the migrated GFP + /GAD1 + interneurons. We conclude that cells migrating through fused organoids can generate multiple MGEderived interneuron subtypes.
The remaining interneurons in the human brain arise from the LGE and CGE 3, 39, 40 . Similar to SOX6 for MGE, the transcription factors COUP-TFII/NR2F2 and SP8 can be used as LGE/CGE fatemapping markers for cortical interneurons 41 . Both SP8 ( Fig. 5f ) and COUP-TFII ( Fig. 5g) were expressed by ~30-40% of the GFP + migrating interneurons (GAD1 + or VGAT + ) in organoid fusions (Fig. 5i,j) . To confirm this result, we also analyzed the expression of markers for LGE/CGE-derived subtypes. We observed calretinin (CR) expression in 4% of the GFP + interneurons (VGAT + ) ( Fig. 5h,j ) but no expression of RELN ( Supplementary Fig. 4 ) or vasoactive intestinal peptide (VIP, data not shown) in these cells; note that, in addition to being expressed by noninterneuron Cajal-Retzius cells, RELN is also expressed by subpopulations of GABAergic MGE-and CGE-derived interneurons 3, 40 . Collectively, our results indicate that organoid fusions contain diverse interneuron subtypes originating from the major ventral forebrain subregions.
Neuronal migratory dynamics in fused cerebral organoids
The migratory dynamics of migrating mouse cortical interneurons has been extensively documented using time-lapse imaging experiments [43] [44] [45] [46] [47] [48] . Migrating interneurons undergo many different modes of migration, both tangential and radial, throughout their development 5, 49 . To examine the behavior of migrating GFP + cells in organoid fusions, we performed time-lapse recordings of migrating GFP + cells in ventral::dorsal CycA organoid fusion slice cultures (Fig. 6a) . The GFP + ventral origin region of the organoid fusion could easily be principle experiment to test whether we could perturb migration in this model, we treated slice cultures of organoids with the CXCR4 antagonist AMD3100 for 3 weeks. Compared with the density of untreated control slices prepared from the same organoid fusion, the density of GFP + cells migrating into GFPdorsal regions was significantly reduced after AMD3100 treatment ( Fig. 6d-e) . Therefore, the cell migration in cerebral organoid fusions depends on CXCR4 activity. Slice cultures of fused organoids could be used to probe small-molecule effects on cell migration and could be developed into larger scale screening platforms in the future.
DISCUSSION
We have developed a cell-migration assay using fused cerebral organoids. The concept of fusing organoids is based on classical coculture experiments. Here we used this technique to study human neuronal cell migration with the experimental control allowed by in vitro 3D cell culture. Ventral::dorsal organoid fusions exhibit robust long-distance cell migration resembling that of ventral-forebrain-derived cortical inhibitory interneurons. This conclusion is based on multiple pieces of data. First, we observed robust migration from ventral into dorsal forebrain regions in cerebral organoid fusions. Second, the migrating cells within organoid fusions express GABAergic markers (GAD1/VGAT). Third, the migrated GFP + cells can produce a variety of interneuron subtypes. In addition, the lack of RELN expression by migrating GFP + cells supports a ventral-forebrainderived interneuron identity. Fourth, the migration dynamics of the GFP + cells in fused organoids resembles the characteristic migratory behavior exhibited by cortical interneurons. Finally, the cell distinguished from the GFPdorsal target region (Fig. 6a) , and we could easily visualize the morphology of the sparsely labeled GFP + cells that had migrated into the dorsal region. Over 3 d, we observed both stationary and motile cells ( Fig. 6b and Supplementary  Videos 1-5) . Surprisingly, we also observed dynamic neuronal processes resembling axons that extended long distances ( Fig. 6c and Supplementary Video 6). We clearly observed cells with a branched leading process that underwent extension and retraction followed by movement of the cell body toward the extending branch (Supplementary Video 1) . Some cells with this behavior exhibited abrupt changes in direction (Supplementary Video 2) . This behavior appears very similar to that described for tangentially migrating interneurons 48 . We observed a different behavior in other cells that exhibited a long leading process extending in a single direction (Supplementary Video 4) . This behavior resembles radial migration. Intriguingly, we also observed cells that exhibited multimodal behavior with branched leading processes but then switched to a single leading process and unidirectional migration (Supplementary Video 5). In summary, the GFP + migrating cells within organoid fusions exhibit migratory characteristics resembling those of migrating cortical interneurons.
3D-culture systems can be effective experimental platforms for drug screening 50, 51 . We developed a slice culture assay (Fig. 6a) to assess the amenability of this fused organoid system for screening applications. Since we observed a large increase in migration from day 30 to day 50 in ventral::dorsal CycA organoid fusions (Fig. 2f) , we probed migration during this period by applying a small-molecule inhibitor. The chemoattractant SDF-1 (CXCL12) and its receptor CXCR4 regulate the migration of interneurons 52 . In a proof-of- ARTICLES organoids from either the origin of migration or the target can be independently genetically manipulated by deriving the organoids from distinct cell lines containing either mutant or wild-type alleles of a gene of interest. This is a powerful genetic tool routinely used in genetic model organisms, but it can now also be used in 3D cultures of developing human brain tissue. migration in organoid fusions was inhibited by CXCR4 inhibition, a known regulator of interneuron migration. Therefore, we have recapitulated the migration of human cortical interneurons from ventral into dorsal forebrain regions. The fact that these cells exhibit both immature and mature neuronal markers indicates that they undergo maturation in the dorsal cortical forebrain target regions. This represents an exciting opportunity to recreate a developing human cortical circuit with a larger repertoire of cellular diversity than was possible to achieve using the previous singular organoid method.
Cerebral organoid methodology exhibits variability, both between batches of differentiations and between different hPSC lines 11, 53 . In this study, we used an iPSC line that was previously used extensively for growing forebrain organoids 9, 12 . As the organoid fusion method relies on proper patterning into dorsal and ventral brain regions for robust ventral-to-dorsal migration to occur, any future hPSC cell lines used in this approach should first be tested for the ability to grow dorsal and ventral brain regions. The qPCR analysis we present can be used for this purpose. Moreover, while we developed the organoid fusion method using a specific previously published cerebral organoid protocol 9, 12 , the concept of organoid fusion should be compatible with any protocol which can grow 3D dorsal and ventral forebrain regions.
An interesting observation was the maintenance of NKX2-1 expression by GFP + cells migrating from ventral into dorsal organoid fusion tissue. This differs from mouse development, where NKX2-1 is downregulated by cortical interneurons as they leave the ventral ganglionic eminence regions and proceed to their dorsal forebrain target regions 37 . However, NKX2-1 + cells have been observed within the dorsal forebrain of embryonic human brain tissue [54] [55] [56] . These data have been interpreted as evidence for the generation of interneurons within dorsal forebrain progenitor regions. An alternative possibility is the prolonged expression of NKX2-1 by migrating cortical interneurons; our data supports the latter possibility.
We also note that the strong effect of CXCR4 inhibition on the migration of cells within organoid fusions differs from observations in the mouse. In CXCR4-knockout and AMD3100-treated mice, interneurons retain the ability to migrate from ventral into dorsal forebrain regions, but the invasion of interneurons into the cortical layers is altered 52, 57 . Whether the CXCR4 effect in human cerebral organoid fusions is another difference between mouse and human interneurons is an interesting avenue of future study. AMD3100/ Plerixafor is an FDA-approved drug, and its safety for use during pregnancy needs to be reinvestigated in light of our results. Nonetheless, these two findings highlight the value of human cerebral organoid fusions to study human interneuron development.
An exciting future application of this technique will be the study of human developmental biology and its relationship to neurological diseases. The fluorescent labeling of cells within one portion of the fused organoids allows visualization of long-distance neuronal migration, potentially via continuous whole-mount imaging in organoid fusions. Immunostaining allows examination of cell identity, which should prove useful in the study of psychiatric diseases (such as Schizophrenia) that are thought to involve selective deficits in specific interneuron subpopulations 58 .
Organoid fusions will also permit dissection of whether specific molecules regulate neuronal migration in a cell-autonomous or cell-nonautonomous manner. For instance, using organoid fusion, Finally, we present slice cultures of fused organoids in which confocal time-lapse imaging can be used to analyze the short-term dynamics of neuronal cell migration. This is an important tool, because some molecules (such as GABA) are known to affect the motility of migrating interneurons 4 , which requires a higher timeresolution analysis of the dynamics of migrating cells. In addition, long-term slice cultures can be used to test how different drug treatments affect cell migration. This presents the opportunity to perform drug screens to determine the effect of many different molecules on interneuron migration.
The organoid fusion method could enable future applications beyond the study of cell migration. As one example, we observed the appearance of axon projections with substantial neurite dynamics, which could be studied further in this system. In addition, although we specifically focused on ventral::dorsal forebrain fusions, fused organoids could be generated starting from other brain regions. Combined with additional brain-region-specific organoid protocols and another recently described cortical spheroid coculture system [59] [60] [61] [62] [63] , organoid fusions could be used to model a vast number of possible brain circuits. Organoid fusion technology should greatly enhance the phenotypic analyses possible with cerebral organoids and expand the future development of in vitro models of human neurological diseases.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
Cell culture. Feeder-dependent human induced pluripotent stem cells (hiPSCs) (Systems Biosciences, cat. no. SC101A-1) were obtained from System Biosciences with pluripotent verification and contamination free. Feeder-dependent hiPSCs were cultured with irradiated mouse embryonic fibroblast (MEF) feeder cells (MTI-GlobalStem, cat. no. 6001G) on gelatin-coated (0.1% gelatin in PBS) six-well culture plates using human embryonic stem cell (hESC) medium: DMEM/F12 (Invitrogen) containing 20 ng/mL bFGF (produced by IMBA institute Molecular Biology Service core facility), 3.5 µL/500 mL media of 2-mercaptoethanol, 20% KnockOut Serum (Invitrogen), 1% GlutaMAX (Invitrogen), 1% MEM-NEAA (Sigma), and 3% FBS. Feeder-free H9 human embryonic stem cells (hESCs) were obtained from WiCell with verified normal karyotype and contamination free. Feeder-free hESCs were cultured on hESCqualified Matrigel (Corning, cat. no. 354277) coated six-well plates using mTeSR1 (Stemcell Technologies). All stem cells were maintained in a 5% CO 2 incubator at 37 °C. Standard procedures were used for culturing and splitting hPSCs as explained previously 12 .
All cell lines were routinely tested for contamination and confirmed mycoplasma negative.
Cloning, molecular biology, and generating hPSC lines. For ubiquitous fluorescent labeling of cells, a reporter construct was inserted into the safe-harbor AAVS1 locus in hPSCs as done previously with TALEN technology 65 using the AAVS1 SA-2A-Puro donor vector (gift from R. Jaenisch, The Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA) as a template. A modified backbone was created that contained flanking tandem repeats of the core chicken HS4 insulator (2xCHS4). Fluorescent reporter expression cassettes were inserted between the flanking insulator sequences. The following expression constructs were inserted into iPSCs: (i) 2xCHS4-EF1a-eGFP-SV40-2xCHS4 and (ii) 2xCHS4-EF1a-tdTomato-SV40-2xCHS4. In feeder-free H9 hESCs, a 2xCHS4-CAG-eGFP-WPRE-SV40-2xCHS4 construct was inserted to enhance the GFP expression for time-lapse imaging experiments. All construct plasmid DNA and sequence files are available from the corresponding author upon request.
hPSCs were prepared for nucleofection as a single-cell suspension using the same cell dissociation procedures as those used for making EBs 12 . The Amaxa nucleofector (Lonza) was used with Stem Cell Kit 1 using 800,000 cells per nucleofection containing 1 µg each of the TALEN guides and 3 µg of the donor plasmid DNA following manufacturer guidelines. After nucleofection, 200 µL of the total 600 µL nucleofection solution was plated onto a 10 cm cell-culture dish. Colonies from single cells were grown for 4 d and then treated with puromycin (Puro) (Jena Bioscience, cat. no. NU-931-5). For feeder-dependent cells, 1.1 µg/mL puro was applied; and for feederfree cells, 0.7 µg/mL was applied. The puro treatment continued for 5-7 d until the surviving colonies were large enough to be picked manually and transferred into a 24-well plate. When splitting the colonies from a 24-well plate, half of the cells were used for genotyping, while the other half were expanded into 12-and then 6-well formats and then used for further experiments. For genotyping, DNA was extracted using the QuickExtract solution (EpiCentre), and PCR was performed using the following primers to identify correctly targeted AAVS1 insertions: (i) Puro (AAVS1_Puro-fwd: tcccctcttccgatgttgag and AAVS1_Puro-rev: gttcttgcagctcggtgac), (ii) eGFP (AAVS1_eGFP-fwd: GAACGGCATCAAGGTGAACT and AAVS1_eGFP-rev: cttcttggccacgtaacctg), and (iii) tdTomato (AAVS1_tdTomato-fwd: ctacaaggtgaagatgcgcg) and (AAVS1_tdTomato-rev: tccagcccctcctactctag). To determine whether the insertion was heterozygous or homozygous, the presence of a WT allele was tested using additional PCR primers: (iv) WT (AAVS1_WT-fwd: tcccctcttccgatgttgag and AAVS1_WT-rev: tccagcccctcctactctag). Cell clones with correctly targeted heteroyzygous or homozygous insertions were archived by freezing with Cell Banker 2 solution (Amsbio, cat. no. 11891) and/or cultured for further experiments.
Cerebral organoid generation and fusion.
Cerebral organoids were generated following the protocol previously developed in our lab 9, 12 with slight modifications. The protocol for generating ventral and dorsal organoids and the characterization of cerebral organoid fusions was tested using a feeder-dependent hiPSC line (Systems Biosciences, cat. no. SC101A-1). A drug-patterning treatment was applied during the neural-induction step of the protocol (~day 5-11) using one of the following treatments: (i) dorsal Unt , no drugs, (ii) Ventral, 2.5 µM IWP2 (Sigma, cat. no. I0536) and 100 nM SAG (Millipore, cat. no. 566660), (iii) dorsal CycA , 5 µM CycA (Calbiochem, cat. no. 239803). Stock drug solutions were created as follows: IWP2 (5 mM in DMSO), SAG (1 mM in H 2 O), and CycA (5 mM in DMSO). Following embedding in Matrigel (Corning, cat. no. 356235), organoids were grown in 10 cm cellculture dishes containing 25 mL of differentiation medium, and after the first media exchange they were maintained on an orbital shaker with medium exchange every 5-7 d. After day 40 of the protocol, when organoids began to grow out of the Matrigel droplet, the differentiation medium was supplemented with 1% Matrigel.
To create organoid fusions, EBs were grown separately and individually patterned using either dorsal Unt , dorsal CycA , or ventral protocols as described above. During Matrigel embedding, two EBs were transferred into the same parafilm well and embedded in a single droplet (~30 µL) of Matrigel. The EBs were gently positioned as close together as possible using a 20 µL pipet tip to ensure the EBs would remain in close proximity within the middle of the solidified Matrigel droplet. The fusion process is very efficient, and it occurs within 1 week when EBs are positioned as close as possible. If EBs were not positioned close enough, then visible space remained between organoids 1 week after embedding. These 'failed' fusions were removed by aspiration. In addition, if the Matrigel droplet disassembled during the embedding process or during additional feedings before fusion had been completed, these organoids were also removed by aspiration.
RNA extraction and qPCR. For each drug-patterning treatment group, 8-12 organoids were collected at day 30-40 into 2 mL RNAse-free tubes and chilled on ice throughout the procedure. The organoids were washed 3× in cold PBS, then the Matrigel was dissolved by incubating the organoids in chilled Cell Recovery Solution (Corning, cat. no. 354253) for 1 h at 4 °C. The dissolved Matrigel was removed by rinsing 3× in cold PBS. RNA was extracted using the RNeasy mini kit (Qiagen). cDNA synthesis was performed using 2 µg of total RNA and the Superscript II (Invitrogen) enzyme according to the manufacturer protocols. qPCR reactions were performed using Sybr Green master mix (Promega) on a BioRad 384-well machine (CXF384) using the following reaction protocol: (i) 95 °C for 3 min, (ii) 95 °C for 10 s, (iii) 62 °C for 10 s, (iv) 72 °C for 40 s, (v) go to 2, 40 cycles, (vi) 95 °C for 1 min, and (vii) 50 °C for 10 s. Quantification was performed in Excel by calculating the ∆Ct value using TBP as a reference gene. Data are presented as expression level (2 -∆Ct ) relative to TBP. The primers used for the qPCR analysis are listed in Supplementary Table 1. Cerebral organoid slice culture and drug treatment. Slice cultures were generated by vibratome sectioning of organoid fusions. The organoid fusion tissue was embedded in 4% low-melt agarose (Biozym, cat. no. 850080) and sectioned in ice-cold PBS (without Ca 2+ /Mg 2+ ) to create 200-250 µm sections. The sections were transferred onto Millicell organotypic inserts (Millipore, cat. no. PICM01250) in six-well cell-culture plates. For time-lapse imaging, sections were cultured for 1-2 d before mounting for imaging using a spinning disk confocal microscope (VisiScope). Sections were cut away from the culture-insert membrane and inverted onto a glassbottom dish. The section was immobilized by placing a cell-culture insert on top of the section and attaching it to the dish using vacuum grease. For drug-, long-term slice cultures were initially cultured overnight in differentiation media (+5% FBS). Then the media were exchanged for fresh media (control) or media containing the CXCR4 inhibitor AMD3100 (Sigma, #A5602) and cultured for an additional 3 weeks before tissue fixation and further immunofluorescent processing.
Histology, cryosectioning, and immunofluorescence. Organoid tissue was collected at the desired age, rinsed 3× in PBS, and fixed in 4% PFA overnight at 4 °C. The next day the tissue was rinsed 3× in PBS and cryoprotected in 30% sucrose in PBS overnight at 4 °C. Then the tissue was incubated 2-4 h in a 1:1 mixture of 30% sucrose-PBS and O.C.T. cryoembedding medium (Sakura, cat. no. 4583). Next, groups of 2-4 organoids were transferred from the sucrose-O.C.T. mixture into a cryomold and filled with O.C.T. The embedded tissue was frozen on dry ice, then it was stored at -80 °C until cryostat sectioning. Frozen organoid tissue was sliced into 20 µm sections using a cryostat (Leica) and collected on superfrost Ultra Plus slides. Tissue sections were arranged such that every 10 th slice was collected sequentially until each slide contained 8-10 sections per block of tissue. The sections were dried overnight and then used for immunofluorescent labeling or stored at -20 °C until ready to stain.
Immunofluorescence was performed on tissue sections directly on slides. The O.C.T. was removed by washing for 10 min in PBS. The sections were postfixed directly on the slides using 4% PFA for 10 min at room temperature (RT) followed by washing 3× for 10 min in PBS. The tissue area was outlined using a hydrophobic PAP pen. Permeabilization/blocking was performed using 5% BSA/0.3% TX100 in PBS with 0.05% sodium azide and incubated 30 min at RT within a dark humidified slide box. Primary antibodies (a table of used primary and secondary antibodies can be found at the end of the method section) were added at the desired dilutions in antibody solution (5% BSA, 0.1% TX100 in PBS with 0.05% sodium azide) and incubated overnight at 4 °C. The primary antibodies used were rabbit anti-FoxG1 (Abcam, ab18259), rabbit anti-TBR1 (Abcam, ab31940), rabbit anti-PV (Swant, PV27), rabbit anti-and the Zeiss Zen implemented stitching algorithm were used. For colocalization of markers, Z-scans at 20× were performed.
Imaging of GFP-stained slides used for quantification and timelapse migration were acquired using a Yokogawa W1 spinning disk confocal microscope (VisiScope, Visitron Systems GmbH, Puchheim, Germany) controlled with the Visitron VisiView software and mounted on the Eclipse Ti-E microscope (Nikon, Nikon Instruments BV) using Ex 488 laser and Em filter 525/50. Measurements were recorded using the 10× 0.45 CFI plan Apo lambda (Nikon, Nikon Instruments BV) objective with the sCMOS camera PCO edge 4.2m. Whole-IHC slice imaging for cell counting was performed using the tile scan acquisition function. Tile scans were then stitched using the Grid/Collection stitching plugin 66 in Fiji. For time-lapse movies, tile scan Z-stacks were recorded.
The cell migration dynamics were analyzed by live time-lapse confocal imaging. To allow for visualization of cell morphology, H9 hESCs containing a bright CAG-eGFP-WPRE-SV40 construct were used to produce ventral tissue. This tissue was fused to unlabeled dorsal CycA organoid tissue generated using the hiPSC line. This yielded ventral/GFP + ::dorsal CycA organoid fusions, which were sliced on a vibratome as described for the slice culture assay. For the time-lapse recordings, we recorded a 300 µm z-stack to account for any drift and curling of the tissue over time. Some sections were not perfectly flat, so a larger z-depth allowed us to account for any unevenness. We set the beginning of the z-stack below the focal plane of the tissue, and then we focused through the detectable fluorescent signal (~50 µm) until no more signal was detectable, and we set the end of the z-stack. This allowed cells to be followed continuously for 3 d. After stitching as performed for cell counting, a maximum Z-projection was created, and the Z-projection time stacks were used for global visualization of cell migration. Cropped regions were created using Fiji and saved as uncompressed AVI files. The AVI files were converted to the mp4 format using Handbrake software to generate Supplementary Videos 1-6.
For imaging the morphology of GFP + cells, z-stacks (0.5 µm z-steps) were collected with the VisiScope spinning disk confocal using the CFI plan Apo lambda 40×/0.95 objective with a 2× lens switch. A maximum Z-projection was created in Fiji.
For generation of figures and presenting images, the 'crop' function, and changing the max/min levels using the 'Brightness/ Contrast' function of Fiji were used.
Cell-density quantification. The number of GFP + cells migrating into GFP-target regions of cerebral organoid fusions was counted manually using the 'Cell Counter' plugin of Fiji. The GFParea in organoid fusions was outlined with the ROI tool, and the area was calculated using the 'measure' function. The cell counts were divided by the area to determine the density of migrated GFP + cells. For the migration timecourse ( Fig. 2e,f) and organoid fusion mixing (Fig. 3b,c) experiments, confocal tile scan images of tissue cryosections were used for quantification. For the long-term slice culture experiment (Fig. 6d,e) , a widefield 5× image containing the GFPregion was used for counting.
Marker expression quantification.
For determining the percentage of ventricular zone (VZ)-like regions expressing various markers, immunostained organoid fusion cryosections were imaged on a spinning disk confocal microscope (see microscopy section) using a 10x objective to collect single-plane, tile scan images of entire organoids. The VZ-like regions were identified in the DAPI channel as circular regions with a packed arrangement of cells in a radialized pattern. The VZ-regions were marked manually using the "Cell Counter" plugin of Fiji. Then the additional channels containing the signal from various marker immunostainings were overlaid, and the VZ-like regions scored for expression of each marker of interest. Two different sections of each organoid were counted and summed. Then the counts for each organoid were calculated as a percentage of total VZ-regions expressing a given marker. The percentages from 4 different organoids from 2 independent differentiations were averaged.
For determining the percentage of GFP + cells expressing various markers, immunostained organoid fusion cryosections were imaged on a spinning disk confocal microscope (see "Imaging and microscopy") using a 20× objective to collect z-stacks (1 µm step size) through the entire 20 µm section. For each organoid, 2-3 positions were collected that included migrated GFP + cells within the dorsal region of an organoid fusion. The number of GFP + cells expressing various markers was counted manually using the 'Cell Counter' plugin of Fiji. The cell counts for each organoid were summed, and the percentage of GFP + cells expressing each marker was calculated. The percentages were averaged across four organoids.
Statistics. All graphs and statistical analyses were generated using Prism 7 (GraphPad). When comparing only two groups ( Figs. 1c  and 6e; Supplementary Fig. 1 , an unpaired two-tailed Student's t-test was performed; for the remaining data comparing multiple groups, a one-way ANOVA with posthoc Tukey's test was used ( Figs. 2f and 3c) . Samples were tested for normality before testing statistical significance. No statistical methods were used to predetermine the sample size. Sample sizes for experiments were estimated based on previous experience with a similar setup that showed significance. Experiments were not randomized, and investigator was not blinded.
Data availability statement. The authors declare that the data that support the findings of this study are available from the corresponding author upon request.
